Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine
Status:
Completed
Trial end date:
2020-01-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the ability of Atorvastatin and N-acetyl cysteine to
elevate the blood (serum) platelet count in patients with Immune Thrombocytopenia as a mean
of a new treatment.